lobbying_activities: 1962824

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1962824	1cbf1771-5091-4d75-aeb8-1644e19fa54c	Q1	COVINGTON & BURLING LLP	11195	CELGENE CORPORATION	2017	first_quarter	PHA	Expressing support for changes to the CREATES Act (S. 3056), Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051), Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act), and Affordable and Safe Prescription Drug Importation Act (S. 469).	HOUSE OF REPRESENTATIVES,SENATE	70000		0	0	2017-04-19T16:43:14.797000-04:00